Biomimetic surface modification of discoidal polymeric particles.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmacology

Background:

• Designing drug delivery nanoparticles traditionally involves self-assembly or top-down methods to control properties for biological responses.
• Achieving specific biological outcomes through optimal material design and property control remains a key challenge in drug delivery research.

Purpose of the Study:

• To engineer discoidal polymeric particles (DPPs) with red blood cell (RBC) membranes to tailor pharmacokinetics.
• To evaluate the biocompatibility and in vivo performance of these biomimetic particles.

Main Methods:

• Fabrication of discoidal polymeric particles (DPPs).
• Re-engineering DPP surfaces with isolated red blood cell (RBC) membranes to create RBC-DPPs.
• In vitro biocompatibility assessment using cell-based assays.
• In vivo pharmacokinetic studies in a mouse model.

Main Results:

• RBC-DPPs demonstrated good biocompatibility in vitro.
• RBC-DPPs exhibited an extended blood circulation half-life compared to bare DPPs.
• Unique later-time kinetics were observed for RBC-DPPs in vivo.

Conclusions:

• Incorporating biomimicry, specifically RBC membranes, can significantly enhance nanoparticle performance.
• Biomimetic particles can potentially cooperate with biological systems for targeted biomedical applications.
• RBC-DPPs represent a promising strategy for advanced drug delivery systems.